| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | GMP |
| Suitable for: | Benzylpenicillin Potassium |
| State: | Powder |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
Pharmaceutical Raw Material Powder Gatifloxacin Mesylate CAS 316819-28 pure Gatifloxacin Mesylate
| Product name | GMP Factory Approved CAS 316819-28-0injectable Gatifloxacin Mesylate |
| Appearance | white Powder |
| cas | 316819-28 |
| Assay | 99% |
| Shelf Life | 24 months when properly stored |
| Storage | Keep in a cool, dry, dark location |
|
What is Gatifloxacin mesylate? Gatifloxacin sold under the brand names Gatiflo, Tequin and Zymar, is an antibiotic of the fourth-generation fluoroquinolone family,[1] that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin for the treatment of respiratory tract infections, having licensed the medication from Kyorin Pharmaceutical Company of Japan. Allergan produces it in eye-drop formulation under the names Zymar and Zymaxid. In many countries, gatifloxacin is also available as tablets and in various aqueous solutions for intravenous therapy. |
Gatifloxacin is currently available in the US and Canada only as an ophthalmic solution. In China it is sold in tablet as well as in eye drop formulations.Ophthalmic anti-infectives are generally well tolerated. The concentration of the drug observed following oral administration of 400 mg gatifloxacin systemically is approximately 800 times higher than that of the 0.5% Gatifloxacin eye drop. Given as an eye drop, Gatifloxacin Ophthalmic Solution 0.3% & 0.5% cause very low systemic exposures. Therefore, the systemic exposures resulting from the gatifloxacin ophthalmic solution are not likely to pose any risk for systemic toxicities.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}